Maplebear Inc.·4

Mar 13, 4:03 PM ET

Fong Morgan 4

4 · Maplebear Inc. · Filed Mar 13, 2026

Research Summary

AI-generated summary of this filing

Updated

Maplebear (CART) GC Fong Morgan Exercises Options and Sells Shares

What Happened

  • Fong Morgan, General Counsel & Secretary of Maplebear, exercised stock options to acquire 110,340 shares at $7.32 per share (total cash paid ~$807,689) and concurrently converted the related derivative (reported as a disposition at $0.00). On the same day (March 11, 2026) Morgan sold a total of 126,083 shares in multiple open-market transactions for aggregate proceeds of approximately $4,676,954.
  • The sales were executed under a Rule 10b5-1 trading plan (adopted December 10, 2025). Reported weighted-average prices for the sales were $36.87, $37.57 and $37.59 for the separate blocks; the filing provides price ranges for the multiple transactions that make up those averages.

Key Details

  • Transaction date: March 11, 2026; Form 4 filed March 13, 2026 (timely filing).
  • Exercises: 110,340 shares acquired at $7.32/share (total ~$807,689); derivative conversion/disposition of 110,340 shares reported at $0.00.
  • Sales: 75,219 shares @ $36.87 (proceeds $2,773,287); 35,121 @ $37.57 ($1,319,633); 10,788 @ $36.87 ($397,784); 4,955 @ $37.59 ($186,250). Total sold = 126,083 shares for ≈ $4.68M.
  • Shares owned after transaction: not specified in the provided filing excerpt.
  • Footnotes: sales executed pursuant to a Rule 10b5-1 plan (adopted 12/10/2025); reported prices are weighted averages and price ranges for the multiple trades are listed in the filing. The option exercised is fully vested and exercisable.

Context

  • This was an option exercise (acquisition) followed by open-market sales. Because the total shares sold (126,083) exceed the shares acquired by exercise (110,340), some of the sold shares were likely from previously owned shares.
  • Sales under an established 10b5-1 plan are commonly pre‑arranged to provide an affirmative defense under insider trading rules; they are routine rather than an immediate unplanned market signal. The filing is factual and does not indicate insider motivation.

Insider Transaction Report

Form 4
Period: 2026-03-11
Fong Morgan
GENERAL COUNSEL & SECRETARY
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-03-11$7.32/sh+110,340$807,689512,726 total
  • Sale

    Common Stock

    [F1][F2]
    2026-03-11$36.87/sh75,219$2,773,287437,507 total
  • Sale

    Common Stock

    [F1][F3]
    2026-03-11$37.57/sh35,121$1,319,633402,386 total
  • Sale

    Common Stock

    [F4][F5]
    2026-03-11$36.87/sh10,788$397,784391,598 total
  • Sale

    Common Stock

    [F4][F6]
    2026-03-11$37.59/sh4,955$186,250386,643 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F1][F7]
    2026-03-11110,340110,340 total
    Exercise: $7.32Exp: 2027-05-16Common Stock (110,340 underlying)
Footnotes (7)
  • [F1]The reported stock option exercise and sales were effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on December 10, 2025.
  • [F2]The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.23 to $37.22 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.23 to $37.97 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The reported sales were effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on December 10, 2025.
  • [F5]The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.25 to $37.24 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F6]The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.26 to $37.98 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F7]The stock option is fully vested and exercisable.
Signature
/s/ Bradley Libuit, Attorney-in-Fact|2026-03-13

Documents

1 file
  • 4
    wk-form4_1773432198.xmlPrimary

    FORM 4